Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Spurred by “the rise of Chinese power,” Japanese automakers Honda and Nissan announced Monday that they are in talks to merge.
The secret ingredients to Lego’s success? A clutch of licensing deals and finding ways to sell Lego sets to kids well over the age of 30.
By expanding its partnership with Ray-Ban, Meta is turning its attention back to building futuristic hardware.